It remains somewhat frustrating that poor growth persists despite the recognition that growth can be efficiently promoted in all stages of CKD by the provision of adequate nutrition, correction of electrolyte and acid-base abnormalities, aggressive treatment of CKD-MBD and anemia, and recombinant growth hormone use. Here, GH1 is linked to anemia (phenotype).